Under normal physiological conditions, however, GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase IV (DPP-4), giving it a fleeting half-life of just a few minutes
Our microdosing approach further minimizes potential side effects
Their strong clinical outcomes and inclusion in leading diabetes guidelines reinforce their market dominance
For GLP-1 medications specifically, this faster absorption can translate to a slightly quicker onset of appetite suppression after each dose, which is directly relevant when your goal is fat loss
This helps patients to feel fuller for longer, reducing the likelihood that theyll reach for additional snacks
Ash has the largest remote medication adherence program in the United States Ash supports multiple large telehealth organizations with their GLP-1 prescription eligibility and weight management programs